Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice

BMC Genetics

Volumn 2, Issue , 2001, Pages

  Anderson, Michael G ^a,b   Smith, Richard S ^a,b   Savinova, Olga V ^b   Hawes, Norman L ^b   Chang, Bo ^b   Zabaleta, Adriana ^b   Wilpan, Robert ^b   Heckenlively, John R ^c   Davisson, Muriel ^b   John, Simon W M ^a,b,d  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b JACKSON LABORATORY   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; TYROSINASE RELATED PROTEIN 1;

ALLELE; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; C57BL MOUSE; CELL DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; DBA MOUSE; DIAGNOSIS; DISEASE SEVERITY; DNA MODIFICATION; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETICS; GLAUCOMA; INTRAOCULAR PRESSURE ABNORMALITY; IRIS; IRIS ATROPHY; IRIS DISEASE; MALE; MOLECULAR MECHANICS; MOUSE; MOUSE STRAIN; MUTATION; NONHUMAN; OPTIC NERVE DISEASE; OPTIC NERVE LESION; PATHOGENESIS; PATHOLOGY; PHENOTYPE; PIGMENT EPITHELIUM; RECESSIVE GENE; RETINA DISEASE; RETINA GANGLION CELL; SEX DIFFERENCE; SPECIES DIFFERENCE; STRAIN DIFFERENCE;

ANIMALS; ATROPHY; DIAGNOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS; GLAUCOMA; IRIS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; MUTATION; OPTIC NERVE DISEASES; PATHOLOGY; PHENOTYPE; PIGMENT EPITHELIUM OF EYE; RETINAL DISEASES; SEX FACTORS; SPECIES SPECIFICITY;

ANIMALIA;

EID: 2942619095     PISSN: 14712156     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2156-2-1     Document Type: Article

References (54)

1. Quigley HA: Number of people with glaucoma worldwide. Br J Ophthalmol 1996, 80:389-393
2. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ: Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995, 36:774-786
3. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME: TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 1997, 115:1031-1035
4. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC: Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 1995, 61:33-44
5. Shields MB, Ritch R, Krupin T: Classifications of the Glaucomas. In: The Glaucomas Edited by Ritch R, Shields MB, Krupin T, vol. 2. pp. 717-725. St. Louis: Mosby; 1996, 717-725
6. Collaborative Normal-Tension Glaucoma Study Group: Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998, 126:487-497
7. Gelatt KN, Brooks DE, Samuelson DA: Comparative glaucomatology. II: The experimental glaucomas. J Glaucoma 1998, 7:282-294
8. Gelatt KN, Brooks DE, Samuelson DA: Comparative glaucomatology. I: The spontaneous glaucomas. J Glaucoma 1998, 7:187-201
9. John SWM, Anderson MG, Smith RS: Mouse genetics: a tool to help unlock the mechanisms of glaucoma. J Glaucoma 1999, 8:400-412
10. Paigen K: A miracle enough: the power of mice. Nat Med 1995, 1:215-220
11. John SWM, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D, Davisson M, Roderick TH, Heckenlively JR: Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 1998, 39:951-962
12. Chang B, Smith RS, Hawes NL, Anderson MG, Zabaleta A, Savinova O, Roderick TH, Heckenlively JR, Davisson MT, John SWM: Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet 1999, 21:405-409
13. Richter CU, Richardson TM, Grant WM: Pigmentary dispersion syndrome and pigmentary glaucoma. A prospective study of the natural history. Arch Ophthalmol 1986, 104:211-215
14. Kampik A, Green WR, Quigley HA, Pierce LH: Scanning and transmission electron microscopic studies of two cases of pigment dispersion syndrome. Am J Ophthalmol 1981, 91:573-587
15. Andersen JS, Pralea AM, DelBono EA, Haines JL, Gorin MB, Schuman JS, Mattox CG, Wiggs JL: A gene responsible for the pigment dispersion syndrome maps to chromosome 7q35-q36. Arch Ophthalmol 1997, 115:384-388
16. Zdarsky E, Favor J, Jackson IJ: The molecular basis of brown, an old mouse mutation, and of an induced revertant to wild type. Genetics 1990, 126:443-449
17. Taylor BA: Recombinant Inbred strains. In: Genetic Variants and Strains of the Laboratory Mouse Edited by Lyon MF, Rastan S, Brown SDM, vol. 2, 3rd ed. pp. 1597-1659. Oxford: Oxford University Press; 1996, 1597-1659
18. Milatovich A, Bolger G, Michaeli T, Francke U: Chromosome localizations of genes for five cAMP-specific phosphodiesterases in man and mouse. Somat Cell Mol Genet 1994, 20:75-86
19. Baumann H, Held WA, Berger FG: The acute phase response of mouse liver. Genetic analysis of the major acute phase reactants. J Biol Chem 1984, 259:566-573
20. Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML: tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 1992, 7:1471-1480
21. Taylor BA, Reifsnyder PC: Typing recombinant inbred mouse strains for microsatellite markers. Mamm Genome 1993, 4:239-242
22. Cornall RJ, Friedman JM, Todd JA: Mouse microsatellites from a flow-sorted 4:6 Robertsonian chromosome. Mamm Genome 1992, 3:620-624
23. Lee BK, Eicher EM: Segregation patterns of endogenous mouse mammary tumor viruses in five recombinant inbred strain sets. J Virol 1990, 64:4568-4572
24. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA: Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996, 114:299-305
25. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB: Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci 1996, 37:1618-1624
26. Sucher NJ, Lipton SA, Dreyer EB: Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res 1997, 37:3483-3493
27. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W: Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993, 75:631-639
28. Cormier RT, Hong KH, Halberg RB, Hawkins TL, Richardson P, Mulherkar R, Dove WF, Lander ES: Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 1997, 17:88-91
29. Cormier RT, Bilger A, Lillich AJ, Halberg RB, Hong KH, Gould KA, Borenstein N, Lander ES, Dove WF: The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene 2000, 19:3182-3192
30. Cox GA, Mahaffey CL, Frankel WN: Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Neuron 1998, 21:1327-1337
31. Obata M, Nishimori H, Ogawa K, Lee GH: Identification of the Par2 (Pulmonary adenoma resistance) locus on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice. Oncogene 1996, 13:1599-1604
32. Letts VA, Schork NJ, Copp AJ, Bernfield M, Frankel WN: A curly-tail modifier locus, mct1, on mouse chromosome 17. Genomics 1995, 29:719-724
33. Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT: The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology 1994, 101:1851-1855
34. Kahn HA, Milton RC: Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham eye study. Arch Ophthalmol 1980, 98:2172-2177
35. Mitchell P, Smith W, Attebo K, Healey PR: Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996, 103:1661-1669
36. Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, Menage MJ: Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992, 99:1499-1504
37. Leske MC, Connell AM, Wu SY, Hyman LG, Schachat AP: Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol 1995, 113:918-924
38. Vaegan , Graham SL, Goldberg I, Buckland L, Hollows FC: Flash and pattern electroretinogram changes with optic atrophy and glaucoma. Exp Eye Res 1995, 60:697-706
39. Fazio DT, Heckenlively JR, Martin DA, Christensen RE: The electroretinogram in advanced open-angle glaucoma. Doc Ophthalmol 1986, 63:45-54
40. Holopigian K, Seiple W, Mayron C, Koty R, Lorenzo M: Electrophysiological and psychophysical flicker sensitivity in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 1990, 31:1863-1868
41. Panda S, Jonas JB: Decreased photoreceptor count in human eyes with secondary angle-closure glaucoma. Invest Ophthalmol Vis Sci 1992, 33:2532-2536
42. Janssen P, Naskar R, Moore S, Thanos S, Thiel HJ: Evidence for glaucoma-induced horizontal cell alterations in the human retina. German J Ophthalmol 1997, 5:378-385
43. Nork TM, Ver Hoeve JN, Poulsen GL, Nickells RW, Davis MD, Weber AJ, Vaegan , Sarks SH, Lemley HL, Millecchia LL: Swelling and loss of photoreceptors in chronic human and experimental glaucomas. Arch Ophthalmol 2000, 118:235-245
44. Hughes WF: Quantitation of ischemic damage in the rat retina. Exp Eye Res 1991, 53:573-582
45. Kalloniatis M: Amino acids in neurotransmission and disease. J Am Optom Assoc 1995, 66:750-757
46. Wityk RJ, Stern BJ: Ischemic stroke: today and tomorrow. Crit Care Med 1994, 22:1278-1293
47. Mori M, Aihara M, Shimizu T: Localization of platelet-activating factor receptor messenger RNA in the rat eye. Invest Ophthalmol Vis Sci 1997, 38:2672-2678
48. Clark GD, Happel LT, Zorumski CF, Bazan NG: Enhancement of hippocampal excitatory synaptic transmission by plateletactivating factor. Neuron 1992, 9:1211-1216
49. Jager GV, van Delft JL, van Haeringen NJ, Verbeij NL, Braquet P: Antagonist of platelet-activating factor prevents prostaglandin E2 induced ocular hypertension in rabbits. Prostaglandins 1993, 45:97-105
50. Bazan NG, Allan G: Signal transduction and gene expression in the eye: a contemporary view of the pro-inflammatory, antiinflammatory and modulatory roles of prostaglandins and other bioactive lipids. Surv Ophthalmol 1997, 41 Suppl 2:S23-34
51. Longphre M, Kleeberger SR: Susceptibility to platelet-activating factor-induced airway hyperreactivity and hyperpermeability: interstrain variation and genetic control. Am J Respir Cell Mol Biol 1995, 13:586-594
52. Hawes NL, Smith RS, Chang B, Davisson M, Heckenlively JR, John SWM: Mouse fundus photography and angiography: a catalogue of normal and mutant phenotypes. Mol Vis 1999, 5:22-53.
53. Jia L, Cepurna WO, Johnson EC, Morrison JC: Patterns of intraocular pressure elevation after aqueous humor outflow obstruction in rats. Invest Ophthalmol Vis Sci 2000, 41:1380-1385
54. John SWM, Hagaman JR, MacTaggart TE, Peng L, Smithes O: Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci 1997, 38:249-253